Cuize Medicine

Hangzhou, China · Founded 2019 · Privately Held (backing)

Developer of pulmonary therapy medication intended to be used for the perioperative period. Cuize Medicine is based in Hangzhou, China and was founded in 2019. Its last reported valuation was $83.4 million in Jun 2025. It has raised $12.6 million.

Last reported valuation
$83.4M
Oct 2026
Priced at
—
Total raised
$12.6M
Last round
—

Who backs Cuize Medicine?

3 investors
InvestorType
Goldport CapitalOther
Jiangguo Investment Management—
Zhejiang Xianju Pharmaceutical Company—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cuize Medicine investors

3 investors are on record for Cuize Medicine, including Goldport Capital, Jiangguo Investment Management and Zhejiang Xianju Pharmaceutical Company.

Free account
More of Cuize Medicine with a free account
  • ·Watch Cuize Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Cuize Medicine. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View